These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 8486778)
1. P53 mutation in acute T cell lymphoblastic leukemia is of somatic origin and is stable during establishment of T cell acute lymphoblastic leukemia cell lines. Yeargin J; Cheng J; Yu AL; Gjerset R; Bogart M; Haas M J Clin Invest; 1993 May; 91(5):2111-7. PubMed ID: 8486778 [TBL] [Abstract][Full Text] [Related]
2. Dissemination and tissue invasiveness in murine acute leukemia associated with acquisition of p53 mutation and loss of wild-type p53. Hsiao M; Wu CY; Low J; Pattengale P; Yeargin J; Haas M Mol Carcinog; 1995 Jun; 13(2):112-21. PubMed ID: 7605579 [TBL] [Abstract][Full Text] [Related]
3. Nonhereditary p53 mutations in T-cell acute lymphoblastic leukemia are associated with the relapse phase. Hsiao MH; Yu AL; Yeargin J; Ku D; Haas M Blood; 1994 May; 83(10):2922-30. PubMed ID: 8180387 [TBL] [Abstract][Full Text] [Related]
4. Alterations of the p53, p21, p16, p15 and RAS genes in childhood T-cell acute lymphoblastic leukemia. Kawamura M; Ohnishi H; Guo SX; Sheng XM; Minegishi M; Hanada R; Horibe K; Hongo T; Kaneko Y; Bessho F; Yanagisawa M; Sekiya T; Hayashi Y Leuk Res; 1999 Feb; 23(2):115-26. PubMed ID: 10071127 [TBL] [Abstract][Full Text] [Related]
5. Establishment of a new human pre-B acute lymphoblastic leukemia cell line (KMO-90) with 1;19 translocation carrying p53 gene alterations. Sotomatsu M; Hayashi Y; Kawamura M; Yugami S; Shitara T Leukemia; 1993 Oct; 7(10):1615-20. PubMed ID: 8412323 [TBL] [Abstract][Full Text] [Related]
6. Infrequent mutations in the P53 gene in primary human T-cell acute lymphoblastic leukemia. Jonveaux P; Berger R Leukemia; 1991 Oct; 5(10):839-40. PubMed ID: 1961018 [TBL] [Abstract][Full Text] [Related]
7. Establishment, characterization, and chromosomal analysis of new leukemic cell lines derived from MT/p210bcr/abl transgenic mice. Honda H; Ohno S; Takahashi T; Takatoku M; Yazaki Y; Hirai H Exp Hematol; 1998 Mar; 26(3):188-97. PubMed ID: 9502614 [TBL] [Abstract][Full Text] [Related]
8. Mutations of the p53 and ras genes in childhood t(1;19)-acute lymphoblastic leukemia. Kawamura M; Kikuchi A; Kobayashi S; Hanada R; Yamamoto K; Horibe K; Shikano T; Ueda K; Hayashi K; Sekiya T Blood; 1995 May; 85(9):2546-52. PubMed ID: 7727782 [TBL] [Abstract][Full Text] [Related]
9. Role of the p53 tumor suppressor gene in the pathogenesis and in the suppression of acute lymphoblastic T-cell leukemia. Yeargin J; Cheng J; Haas M Leukemia; 1992; 6 Suppl 3():85S-91S. PubMed ID: 1602834 [TBL] [Abstract][Full Text] [Related]
10. Structural and functional analysis of oncogenes and tumor suppressor genes in adult T-cell leukemia/lymphoma shows frequent p53 mutations. Cesarman E; Chadburn A; Inghirami G; Gaidano G; Knowles DM Blood; 1992 Dec; 80(12):3205-16. PubMed ID: 1361372 [TBL] [Abstract][Full Text] [Related]
11. Suppression of acute lymphoblastic leukemia by the human wild-type p53 gene. Cheng J; Yee JK; Yeargin J; Friedmann T; Haas M Cancer Res; 1992 Jan; 52(1):222-6. PubMed ID: 1727382 [TBL] [Abstract][Full Text] [Related]
12. Gain-of-function mutations of the p53 gene induce lymphohematopoietic metastatic potential and tissue invasiveness. Hsiao M; Low J; Dorn E; Ku D; Pattengale P; Yeargin J; Haas M Am J Pathol; 1994 Sep; 145(3):702-14. PubMed ID: 8080050 [TBL] [Abstract][Full Text] [Related]
13. P53 gene mutation in a T-acute lymphoblastic leukemia cell line (loucy) with t(16:20) and 5q- chromosomal aberrations. Prokocimer M; Peller S; Ben-Bassat H; Goldfinger N; Rotter V Leuk Lymphoma; 1998 May; 29(5-6):607-11. PubMed ID: 9643574 [TBL] [Abstract][Full Text] [Related]
14. Mutations in the p53 gene in myelodysplastic syndromes. Jonveaux P; Fenaux P; Quiquandon I; Pignon JM; Laï JL; Loucheux-Lefebvre MH; Goossens M; Bauters F; Berger R Oncogene; 1991 Dec; 6(12):2243-7. PubMed ID: 1766671 [TBL] [Abstract][Full Text] [Related]
15. Frequent mutations in the p53 tumor suppressor gene in human leukemia T-cell lines. Cheng J; Haas M Mol Cell Biol; 1990 Oct; 10(10):5502-9. PubMed ID: 2144611 [TBL] [Abstract][Full Text] [Related]
16. [Alterations of the p53 gene and clinical features in childhood acute lymphoblastic leukemia]. Kawamua M; Hayashi Y; Bessho F; Yanagisawa M; Hanada R; Yamamoto K; Horibe K; Hongo T; Ueda K Rinsho Ketsueki; 1997 Sep; 38(9):719-26. PubMed ID: 9364861 [TBL] [Abstract][Full Text] [Related]
17. In vitro validation of gamma-secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemia. De Keersmaecker K; Lahortiga I; Mentens N; Folens C; Van Neste L; Bekaert S; Vandenberghe P; Odero MD; Marynen P; Cools J Haematologica; 2008 Apr; 93(4):533-42. PubMed ID: 18322257 [TBL] [Abstract][Full Text] [Related]
18. Alternative splicing of the p53 tumor suppressor gene in the Molt-4 T-lymphoblastic leukemia cell line. Chow VT; Quek HH; Tock EP Cancer Lett; 1993 Sep; 73(2-3):141-8. PubMed ID: 8221626 [TBL] [Abstract][Full Text] [Related]
19. p53 and N-ras mutations in two new leukemia cell lines established from a patient with multilineage CD7-positive acute leukemia. Abo J; Inokuchi K; Dan K; Nomura T Blood; 1993 Nov; 82(9):2829-36. PubMed ID: 7693050 [TBL] [Abstract][Full Text] [Related]
20. Frequent p53 mutation in relapsed acute lymphoblastic leukemia with cytogenetic instability: a longitudinal analysis. Tang JL; Tien HF; Lin MT; Chen PJ; Chen YC Anticancer Res; 1998; 18(2B):1273-8. PubMed ID: 9615800 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]